Home / Propranolol / United States
US ATC C07AA05 · updated 2 Nov 2026
Propranolol shortage in United States
Is there a Propranolol shortage in United States?
Yes. As of 2 Nov 2026, 2 Propranolol products are reported short in United States, the first since 31 Oct 2023. No return date has been given. Main reason: active ingredient shortage.
Also short in Canada, Germany, France, Italy, Spain, Belgium. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Propranolol Hydrochloride, Injection, 1 mg/1 mL (NDC 0143-9872-10) | Hikma Pharmaceuticals USA, Inc. | 31 Oct 2023 | not given | Active ingredient shortage Shortage of an active ingredient |
| US | Propranolol Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-604-01) | Fresenius Kabi USA, LLC | 31 Oct 2023 | not given | Distribution or logistics Delay in shipping of the drug |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).